CDK4/6InhibitorsBI-RADSRelapseTriple +/-BreastCancerRadiotherapyPaclitaxelAdjuvantTherapy1 in 8womenAromataseInhibitorsCapecitabineMastodyniaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEstradiolProgestinPagetDiseasePathologicResponseDocetaxelLumpectomyAyurvedaMethotrexateAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenStagingPhysicalactivity mayreduce therisk of breastcancersAbsoluteRiskDoseDenseTherapyMegestrolAcetateLymphoscintigraphyPalpationFlowCytometryMRIMorpheaFamilyHistoryCytotoxicCachexiaACChemotherapyHER-2RaloxifeneFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55DimplingTumorGradeTamoxifenFISHGuaranteedRenewableInsuranceBrachytherapySelf-examinationmTORInhibitorsAnastrozoleEGFRNeoadjuvantTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyKappaEpsilonEstrogenMetastasisBiopsyOvarianSuppressionAntiemeticGermlineMutationER+DefinitiveSurgeryKi-67RateCalcificationsGeneMutationWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ChemopreventionCheckpointInhibitorPhyllodesTumorSERMGenomicTestingBreastCancerIn-situCarcinomaCMFChemotherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCystBilateralProphylacticMastectomyPalbociclibMultifocalTumorsHormoneReplacementTherapyMultimodalityTherapyImmunotherapyAngiogenesisCo-survivorApoptosis5-FluorouracilHerceptinLumpRADAdenocarcinomaTyrosine-KinaseInhibitorIntraductalPapillomaChemotherapyPARPInhibitorsBreastTomosynthesisECOGScoreCyclophosphamideGailModelGeneticCounselingDoxorubicinLymphNodeStatusPrecisionMedicineLCISOligometastasesAntibodyTherapyHormoneReceptorStatusAdvocacyFibroadenomaAxillarySamplingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerER-LapatinibBOCABRCAGeneBevacizumabGeneticPredispositionCytostaticMastectomyAlopeciaDown-StagingCAMPI3KinaseInhibitorsCDK4/6InhibitorsBI-RADSRelapseTriple +/-BreastCancerRadiotherapyPaclitaxelAdjuvantTherapy1 in 8womenAromataseInhibitorsCapecitabineMastodyniaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearEstradiolProgestinPagetDiseasePathologicResponseDocetaxelLumpectomyAyurvedaMethotrexateAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenStagingPhysicalactivity mayreduce therisk of breastcancersAbsoluteRiskDoseDenseTherapyMegestrolAcetateLymphoscintigraphyPalpationFlowCytometryMRIMorpheaFamilyHistoryCytotoxicCachexiaACChemotherapyHER-2RaloxifeneFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55DimplingTumorGradeTamoxifenFISHGuaranteedRenewableInsuranceBrachytherapySelf-examinationmTORInhibitorsAnastrozoleEGFRNeoadjuvantTherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyKappaEpsilonEstrogenMetastasisBiopsyOvarianSuppressionAntiemeticGermlineMutationER+DefinitiveSurgeryKi-67RateCalcificationsGeneMutationWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ChemopreventionCheckpointInhibitorPhyllodesTumorSERMGenomicTestingBreastCancerIn-situCarcinomaCMFChemotherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCystBilateralProphylacticMastectomyPalbociclibMultifocalTumorsHormoneReplacementTherapyMultimodalityTherapyImmunotherapyAngiogenesisCo-survivorApoptosis5-FluorouracilHerceptinLumpRADAdenocarcinomaTyrosine-KinaseInhibitorIntraductalPapillomaChemotherapyPARPInhibitorsBreastTomosynthesisECOGScoreCyclophosphamideGailModelGeneticCounselingDoxorubicinLymphNodeStatusPrecisionMedicineLCISOligometastasesAntibodyTherapyHormoneReceptorStatusAdvocacyFibroadenomaAxillarySamplingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerER-LapatinibBOCABRCAGeneBevacizumabGeneticPredispositionCytostaticMastectomyAlopeciaDown-StagingCAMPI3KinaseInhibitors

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. CDK4/6 Inhibitors
  2. BI-RADS
  3. Relapse
  4. Triple +/- Breast Cancer
  5. Radiotherapy
  6. Paclitaxel
  7. Adjuvant Therapy
  8. 1 in 8 women
  9. Aromatase Inhibitors
  10. Capecitabine
  11. Mastodynia
  12. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  13. Estradiol
  14. Progestin
  15. Paget Disease
  16. Pathologic Response
  17. Docetaxel
  18. Lumpectomy
  19. Ayurveda
  20. Methotrexate
  21. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  22. Staging
  23. Physical activity may reduce the risk of breast cancers
  24. Absolute Risk
  25. Dose Dense Therapy
  26. Megestrol Acetate
  27. Lymphoscintigraphy
  28. Palpation
  29. Flow Cytometry
  30. MRI
  31. Morphea
  32. Family History
  33. Cytotoxic
  34. Cachexia
  35. AC Chemotherapy
  36. HER-2
  37. Raloxifene
  38. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  39. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  40. Dimpling
  41. Tumor Grade
  42. Tamoxifen
  43. FISH
  44. Guaranteed Renewable Insurance
  45. Brachytherapy
  46. Self-examination
  47. mTOR Inhibitors
  48. Anastrozole
  49. EGFR
  50. Neoadjuvant Therapy
  51. Women ages 40+ should have a clinical breast exam at least yearly
  52. Kappa Epsilon
  53. Estrogen
  54. Metastasis
  55. Biopsy
  56. Ovarian Suppression
  57. Antiemetic
  58. Germline Mutation
  59. ER+
  60. Definitive Surgery
  61. Ki-67 Rate
  62. Calcifications
  63. Gene Mutation
  64. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  65. Chemoprevention
  66. Checkpoint Inhibitor
  67. Phyllodes Tumor
  68. SERM
  69. Genomic Testing
  70. Breast Cancer
  71. In-situ Carcinoma
  72. CMF Chemotherapy
  73. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  74. Cyst
  75. Bilateral Prophylactic Mastectomy
  76. Palbociclib
  77. Multifocal Tumors
  78. Hormone Replacement Therapy
  79. Multimodality Therapy
  80. Immunotherapy
  81. Angiogenesis
  82. Co-survivor
  83. Apoptosis
  84. 5-Fluorouracil
  85. Herceptin
  86. Lump
  87. RAD
  88. Adenocarcinoma
  89. Tyrosine-Kinase Inhibitor
  90. Intraductal Papilloma
  91. Chemotherapy
  92. PARP Inhibitors
  93. Breast Tomosynthesis
  94. ECOG Score
  95. Cyclophosphamide
  96. Gail Model
  97. Genetic Counseling
  98. Doxorubicin
  99. Lymph Node Status
  100. Precision Medicine
  101. LCIS
  102. Oligometastases
  103. Antibody Therapy
  104. Hormone Receptor Status
  105. Advocacy
  106. Fibroadenoma
  107. Axillary Sampling
  108. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  109. ER-
  110. Lapatinib
  111. BOCA
  112. BRCA Gene
  113. Bevacizumab
  114. Genetic Predisposition
  115. Cytostatic
  116. Mastectomy
  117. Alopecia
  118. Down-Staging
  119. CAM
  120. PI3 Kinase Inhibitors